52 completed, 14 terminated, 13 recruiting, 9 unknown. 101 Phase 2, 17 Phase 1, 7 Phase 3.
Follow Peritoneal Diseases: new trials by email Literature Review of Peritoneal Diseases trials Research Report on Peritoneal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE) GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) - Colorectal Cancer, Gastric Cancers | Phase 2 / Phase 3 | Recruiting | GE Healthcare | 175 | 2026-10-01 | 2026-06-17 |
| Paricalcitol Versus Pirfenidone for Improving Surgical Resectability in Patients With Peritoneal Cancer Paricalcitol, pirfenidone - Peritoneal (Metastatic) Cancer, Peritoneal Carcinoma | Phase 2 | Not yet recruiting | Patrick Wagner, MD, FACS | 74 | 2026-09-01 | 2026-10-05 |
| MRI-Guided Adaptive Radiotherapy for Limited Peritoneal Metastases (MARACAS Trial). MRI-guided stereotactic body radiotherapy - Peritoneal Carcinomatosis, Oligometastatic Disease | Phase 2 | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 34 | 2026-07-01 | 2026-05-18 |
| Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC) Modified early post-operative intraperitoneal chemotherapy (mEPIC) - Peritoneal Carcinomatosis, Appendiceal Neoplasms | Phase 2 | Recruiting | Ciusss de L'Est de l'Île de Montréal | 25 | 2026-05-01 | 2026-05-14 |
| Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis Canagliflozin 300 MG - ESRD, CKD (Chronic Kidney Disease) Stage 5D | Phase 2 | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2026-02-01 | 2026-03-16 |
| Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining) Heated intra-peritoneal chemotherapy, Aerosolized intra-peritoneal chemotherapy - Peritoneal (Metastatic) Cancer, Peritoneal Carcinomatosis | Phase 2 | Recruiting | Patrick Wagner, MD, FACS | 200 | 2026-01-05 | 2026-02-27 |
| Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer Pressurized intraperitoneal aerosol chemotherapy (PIPAC) using paclitaxel - Ovarian Neoplasms, Peritoneal Neoplasms | Phase 1 / Phase 2 | Not yet recruiting | Seoul National University Hospital | 53 | 2026-01-01 | 2025-12-09 |
| Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity Standard of Care Chemotherapy, Biospecimen Collection, Computed Tomography - Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 / Phase 3 | Recruiting | ECOG-ACRIN Cancer Research Group | 148 | 2025-10-24 | 2026-10-05 |
| Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer Cisplatin, Mitomycin - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Recruiting | University of Chicago | 21 | 2025-09-09 | 2026-09-08 |
| Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg - Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Recruiting | Corcept Therapeutics | 270 | 2025-04-11 | 2026-07-16 |
| Intensification Treatment of Ovarian Cancer by PIPAC PIPAC - Advanced Epithelial Ovarian Cancer, Peritoneal Carcinomatosis | Phase 2 | Recruiting | Moscow Regional Oncological Dispensary | 160 | 2025-04-02 | 2026-04-07 |
| Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy oral iohexol, Lymphangiography and Embolization - Chylous Ascites, Abdominal Neoplasm | Phase 2 | Completed | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 42 | 2025-02-15 | 2026-03-06 |
| Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients Placebo, Magnesium - Hemodynamics Instability, Pain After Surgery | Phase 1 / Phase 2 | Completed | Ziauddin University | 60 | 2025-01-06 | 2026-09-02 |
| A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery Radspherin - Peritoneal Carcinomatosis, Ovarian Cancer | Phase 2 | Recruiting | Oncoinvent Solutions AS | 114 | 2024-06-15 | 2026-05-20 |
| Galunisertib Combined With Capecitabine in Advanced CRC With PM Galunisertib plus capecitabine - Colorectal Cancer Metastatic, Peritoneal Carcinomatosis | Phase 1 / Phase 2 | Active not recruiting | The Netherlands Cancer Institute | 31 | 2023-07-28 | 2026-07-13 |
| Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma. Indocyanine green - Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Terminated | Laval University | 11 | 2022-12-15 | 2024-04-02 |
| Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis Paclitaxel, Nilotinib, ECG - Gynecologic Cancer, Gynecologic Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 21 | 2022-10-13 | 2026-06-25 |
| Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases Preoperative systematic therapy, CRS+HIPEC, Postoperative chemotherapy - Colorectal Neoplasms, Colorectal Cancer | Phase 2 | Unknown | Sun Yat-sen University | 168 | 2022-06-01 | 2022-04-29 |
| Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis Intraperitoneal chemotherapy - Gastric Cancer, Peritoneal Carcinomatosis | Phase 2 | Unknown | Instituto do Cancer do Estado de São Paulo | 30 | 2022-06-01 | 2023-03-23 |
| Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine - Peritoneal Carcinomatosis, Pancreas Neoplasm | Phase 2 | Unknown | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 38 | 2022-03-01 | 2024-02-26 |
Showing 20 of 101. Sign in to see all of them.
Peritoneal Neoplasms (87) · Ovarian Neoplasms (28) · Fallopian Tube Neoplasms (19) · Colorectal Neoplasms (18) · Stomach Neoplasms (13) · Neoplasms (12) · Peritonitis (8) · Carcinoma (7) · Appendiceal Neoplasms (6) · Colonic Neoplasms (6) · Carcinoma, Ovarian Epithelial (4) · Neoplasm Metastasis (4) · Adenocarcinoma (3) · Ascites (3) · Gastrointestinal Neoplasms (3)
Digestive System Diseases (101) · Digestive System Neoplasms (88) · Neoplasms by Site (88) · Abdominal Neoplasms (86) · Neoplasms (78) · Gastrointestinal Diseases (35) · Endocrine Gland Neoplasms (33) · Endocrine System Diseases (32) · Female Urogenital Diseases (31) · Female Urogenital Diseases and Pregnancy Complications (31) · Urogenital Diseases (31) · Gastrointestinal Neoplasms (30) · Adnexal Diseases (29) · Genital Diseases (29)
Cisplatin (13) · Hyperthermic Intraperitoneal Chemotherapy (13) · Paclitaxel (13) · Cytoreduction Surgical Procedures (10) · Oxaliplatin (9) · Fluorouracil (7) · Mitomycin (6) · Bevacizumab (5) · Carboplatin (5) · Doxorubicin (4) · Leucovorin (4) · Docetaxel (3) · catumaxomab (3) · Acetylcysteine (2) · Capecitabine (2)
National Cancer Institute (NCI) (7) · Michael Bau Mortensen (3) · University Hospital, Ghent (3) · AGO Study Group (2) · Eli Lilly and Company (2) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2) · Hospices Civils de Lyon (2) · Jules Bordet Institute (2) · Koen Rovers (2) · M.D. Anderson Cancer Center (2) · Novartis Pharmaceuticals (2) · Patrick Wagner, MD, FACS (2) · TC Erciyes University (2) · AIO-Studien-gGmbH (1) · ARCAGY/ GINECO GROUP (1)
United States (39) · Belgium (11) · Germany (10) · France (8) · Canada (7) · China (6) · Italy (6) · Netherlands (6) · Spain (6) · Denmark (3) · Russia (3) · South Korea (3) · Austria (2) · Norway (2) · Poland (2)
Gabriel Liberale, MD (2) · Patrick Wagner, MD (2) · Wim P Ceelen, MD, PhD (2) · Agustin Garcia, MD (1) · Alexandra R Brandt-Kerkhof, MD (1) · Alexandre Brind'Amour, MD (1) · Alexey S. Dzasokhov, MD, PhD (1) · Andre Roncon Dias, MD, PhD (1) · Andrea Di Giorgio, MD (1) · Andrew Blakely, M.D. (1) · Andrew M Blakely, M.D. (1) · Ardaman Shergill (1)
PMID 11762804, PMID 14745444, PMID 16452199, PMID 16790085, PMID 17513629, PMID 19181369, PMID 19617379, PMID 19942597, PMID 20008305, PMID 20068097, PMID 20500867, PMID 20525328, PMID 21424369, PMID 21551083, PMID 21733566, PMID 22096279, PMID 23377563, PMID 23474348, PMID 23765417, PMID 23904932, PMID 24006094, PMID 24275155, PMID 24447964, PMID 24756812, PMID 25073872, PMID 25254563, PMID 25885838, PMID 26673788, PMID 27520560, PMID 27633880, PMID 28529748, PMID 29149865, PMID 29773661, PMID 29899763, PMID 30131226, PMID 30463745, PMID 30755498, PMID 30832742, PMID 30911655, PMID 30911656, PMID 30911669, PMID 31023318, PMID 31303716, PMID 31331370, PMID 31352425, PMID 31779675, PMID 31862004, PMID 32556731, PMID 32572849, PMID 33037105
2016 (3), 2009 (2), 2017 (1), 2019 (1), 2025 (1), P01CA132714 (1), U10CA180820 (1)